id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-1551-0016,FDA,FDA-2014-D-1551,"Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry; Draft Guidance",Other,Guidance,2020-07-30T04:00:00Z,2020,7,2020-07-30T04:00:00Z,,2024-11-06T23:38:18Z,,1,0,09000064847bd0c5
FDA-2014-D-1551-0015,FDA,FDA-2014-D-1551,"Pregnancy, Lactation, and Reproductive Potential: Labeling for Human Prescription Drug and Biological Products—Content and Format; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2020-07-30T04:00:00Z,2020,7,2020-07-30T04:00:00Z,2020-09-29T03:59:59Z,2020-09-28T10:28:10Z,2020-16530,0,0,09000064847bdf63